Joseph E. Payne
54Patents
11h-index
45Co-inventors
74Inventor score
Filing activity: Oct 6, 2005 → Aug 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8741867B2 | Retinoid-liposomes for treating fibrosis | Chemistry; Metallurgy | 31 | Active |
| US8664376B2 | Retinoid-liposomes for enhancing modulation of HSP47 expression | Chemistry; Metallurgy | 26 | Active |
| US9670152B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 23 | Active |
| US9011903B2 | Cationic lipids for therapeutic agent delivery formulations | Chemistry; Metallurgy | 22 | Active |
| US9365610B2 | Asymmetric ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 20 | Active |
| US10487105B2 | Trinucleotide MRNA cap analogs | Chemistry; Metallurgy | 18 | Active |
| US9593077B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 18 | Active |
| US9567296B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 17 | Active |
| US9896413B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 14 | Active |
| US9580711B2 | Lipid particles with asymmetric cationic lipids for RNA delivery | Chemistry; Metallurgy | 14 | Active |
| US9850202B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 11 | Active |
| US9456984B2 | Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier | Chemistry; Metallurgy | 10 | Active |
| US8609852B2 | Thiazolyl mGluR5 antagonists and methods for their use | Chemistry; Metallurgy | 10 | Active |
| US9951002B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 10 | Active |
| US9242001B2 | Cationic lipids for therapeutic agent delivery formulations | Chemistry; Metallurgy | 10 | Active |
| US9393315B2 | Compounds for targeting drug delivery and enhancing siRNA activity | Emerging Cross-Sectional Technologies | 9 | Active |
| US9963424B2 | Cationic lipids for therapeutic agent delivery formulations | Chemistry; Metallurgy | 8 | Active |
| US10526284B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 7 | Active |
| US10227302B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 6 | Active |
| US9308267B2 | Lipids for therapeutic agent delivery formulations | Emerging Cross-Sectional Technologies | 6 | Active |
| US10980895B2 | Ionizable cationic lipid for RNA delivery | Chemistry; Metallurgy | 5 | Active |
| US10815463B2 | Messenger UNA molecules and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US10233148B2 | Aromatic ionizable cationic lipid | Chemistry; Metallurgy | 5 | Active |
| US9982259B2 | Transthyretin allele selective UNA oligomers for gene silencing | Chemistry; Metallurgy | 4 | Active |
| US10781169B2 | Method of synthesis of an ionizable cationic lipid | Chemistry; Metallurgy | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.